Nixon Peabody Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
Nixon Peabody Trust's ABBV Position: Q2 2026 in Review
Nixon Peabody Trust increased its AbbVie (ABBV) stake by 1.8% in Q2 2026, buying an estimated $31.6K and bringing the position to 8,249 shares worth $2.08M. The position accounts for 0.15% of the portfolio, ranked #77.
Nixon Peabody Trust first reported a position in ABBV in Q3 2021 and has held it in 14 quarters since. 1,743 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Nixon Peabody Trust held 8,249 shares of AbbVie worth $2.08M as of Q2 2026.
- Nixon Peabody Trust bought 147 AbbVie shares in Q2 2026, an estimated $31.6K.
- AbbVie made up 0.15% of Nixon Peabody Trust's portfolio in Q2 2026, its #77 holding.
- Nixon Peabody Trust first reported a position in AbbVie in Q3 2021 and has held it in 14 quarters since.
- 1,743 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.